Literature DB >> 10029071

Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene.

I Horikawa1, P L Cable, C Afshari, J C Barrett.   

Abstract

Activation of telomerase is one of the rate-limiting steps in human cell immortalization and carcinogenesis Human telomerase is composed of at least two protein subunits and an RNA component. Regulation of expression of the catalytic subunit, human telomerase reverse transcriptase (hTERT), is suggested as the major determinant of the enzymatic activity. We report here the cloning and characterization of the 5'-regulatory region of the hTERT gene. The highly GC-rich content of the 5' end of the hTERT cDNA spans to the 5'-flanking region and intron 1, making a CpG island. A 1.7-kb DNA fragment encompassing the hTERT gene promoter was placed upstream of the luciferase reporter gene and transiently transfected into human cell lines of fibroblastic and epithelial origins that differed in their expression of the endogenous hTERT gene. Endogenous hTERT-expressing cells, but not nonexpressing cells, showed high levels of luciferase activity, suggesting that the regulation of hTERT gene expression occurs mainly at the transcriptional level. Additional luciferase assays using a series of constructs containing unidirectionally deleted fragments revealed that a 59-bp region (-208 to -150) is required for the maximal promoter activity. The region contains a potential Myc oncoprotein binding site (E-box), and cotransfection of a c-myc expression plasmid markedly enhanced the promoter activity, suggesting a role of the Myc protein in telomerase activation. Identification of the regulatory regions of the hTERT promoter sequence will be essential in understanding the molecular mechanisms of positive and negative regulation of telomerase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10029071

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  114 in total

Review 1.  Natural and pharmacological regulation of telomerase.

Authors:  Jean-Louis Mergny; Jean-François Riou; Patrick Mailliet; Marie-Paule Teulade-Fichou; Eric Gilson
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

Review 2.  Complex regulation of telomerase activity: implications for cancer therapy.

Authors:  K S Elenitoba-Johnson
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

3.  Regulatory mechanisms of human and mouse telomerase reverse transcriptase gene transcription: distinct dependency on c-Myc.

Authors:  Tsukasa Fujiki; Miyako Udono; Keishi Kadooka; Shuntaro Yamashita; Takumi Miura; Sanetaka Shirahata; Yoshinori Katakura
Journal:  Cytotechnology       Date:  2010-05-08       Impact factor: 2.058

4.  Functional genomics of tumor suppressor miR-196b in T-cell acute lymphoblastic leukemia.

Authors:  Suman Bhatia; Deepak Kaul; Neelam Varma
Journal:  Mol Cell Biochem       Date:  2010-10-06       Impact factor: 3.396

5.  Cloning and expression pattern of alkaline phosphatase during the development of Paralichthys olivaceus.

Authors:  Z Y Shi; X W Chen; Y F Gu
Journal:  Fish Physiol Biochem       Date:  2010-10-05       Impact factor: 2.794

6.  E2F-1 represses transcription of the human telomerase reverse transcriptase gene.

Authors:  D L Crowe; D C Nguyen; K J Tsang; S Kyo
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

7.  Expression of MTLC gene in gastric carcinoma.

Authors:  Guang-Bin Qiu; Li-Guo Gong; Dong-Mei Hao; Zhi-Hong Zhen; Kai-Lai Sun
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

8.  Potent antitumoral efficacy of a novel replicative adenovirus CNHK300 targeting telomerase-positive cancer cells.

Authors:  C-Q Su; J Sham; H-B Xue; X-H Wang; D Chua; Z-F Cui; L-H Peng; L-F Li; L-H Jiang; M-C Wu; Q-J Qian
Journal:  J Cancer Res Clin Oncol       Date:  2004-07-09       Impact factor: 4.553

9.  Down regulation of human telomerase reverse transcriptase (hTERT) expression by BIBR1532 in human glioblastoma LN18 cells.

Authors:  C Lavanya; Manjunatha M Venkataswamy; M K Sibin; M M Srinivas Bharath; G K Chetan
Journal:  Cytotechnology       Date:  2018-03-15       Impact factor: 2.058

10.  BRG1, the ATPase subunit of SWI/SNF chromatin remodeling complex, interacts with HDAC2 to modulate telomerase expression in human cancer cells.

Authors:  Shu Wu; Yuanlong Ge; Laiqiang Huang; Haiying Liu; Yong Xue; Yong Zhao
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.